... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
chalcogen molecular entity >
oxygen molecular entity >
organooxygen compound >
carbonyl compound >
n-[(2r,4as,12as)-2-[2-(2,3-dihydro-1h-inden-5-ylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
chalcogen molecular entity >
organochalcogen compound >
organooxygen compound >
carbonyl compound >
n-[(2r,4as,12as)-2-[2-(2,3-dihydro-1h-inden-5-ylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
heteroorganic entity >
organochalcogen compound >
organooxygen compound >
carbonyl compound >
n-[(2r,4as,12as)-2-[2-(2,3-dihydro-1h-inden-5-ylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
organic molecule >
organic oxo compound >
carbonyl compound >
n-[(2r,4as,12as)-2-[2-(2,3-dihydro-1h-inden-5-ylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
... >
chemical entity >
molecular entity >
polyatomic entity >
molecule >
organic molecule >
organic oxo compound >
carbonyl compound >
n-[(2r,4as,12as)-2-[2-(2,3-dihydro-1h-inden-5-ylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
... >
chemical entity >
molecular entity >
polyatomic entity >
heteroatomic molecular entity >
halide >
organohalogen compound >
n-[(2r,4as,12as)-2-[2-(2,3-dihydro-1h-inden-5-ylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
halogen molecular entity >
halide >
organohalogen compound >
n-[(2r,4as,12as)-2-[2-(2,3-dihydro-1h-inden-5-ylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
heteroorganic entity >
organohalogen compound >
n-[(2r,4as,12as)-2-[2-(2,3-dihydro-1h-inden-5-ylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
اصطلاح مرجح
n-[(2r,4as,12as)-2-[2-(2,3-dihydro-1h-inden-5-ylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
اینچی
-
InChI=1S/C32H32ClN3O5/c1-36-27-13-12-23(17-30(37)34-21-10-9-19-5-4-6-20(19)15-21)41-29(27)18-40-28-14-11-22(16-25(28)32(36)39)35-31(38)24-7-2-3-8-26(24)33/h2-3,7-11,14-16,23,27,29H,4-6,12-13,17-18H2,1H3,(H,34,37)(H,35,38)/t23-,27+,29-/m1/s1
اینچیکی
-
OTEDYSPKROHHLA-FNHKZSGOSA-N
اسمایلٓ
-
CN1[C@H]2CC[C@@H](O[C@@H]2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=CC=CC=C4Cl)CC(=O)NC5=CC6=C(CCC6)C=C5
-
N [(2R,4aS,12aS) 2 [2 (2,3 dihydro 1H inden 5 ylamino) 2 oxoethyl] 5 methyl 6 oxo 2,3,4,4a,12,12a hexahydropyrano[2,3 c][1,5]benzoxazocin 8 ylrobenzami 2
URI
http://www.irandoc.acir/onto/irandoc/CHEBI:103129